THE ANTIBODY SERIES 2023
We are delighted to announce that The Antibody Series 2023 will be held at Vidago Palace, a stunning historical Palace, nestled within 250 acres of woodlands in the heart of Viadgo, Portugal.
Date & Time
September 6 - 7, 2023
8:00 AM - - 6:00 PM
Join us on our official LinkedIn Group!
Get notified on the latest updates & Access to the live stream!
Receive regular updates by joining the official ANTIBODY SERIES LinkedIn group!
Meet the Speakers of 2022
We are extremely excited to showcase the line-up of expert and experienced speakers from industry and academia.
Speakers in alphabetical order
LABORATORY HEAD ENGINEERED PROTEIN THERAPEUTICS
Dr. Daniel Bedinger
Manager, Applications Science
PhD, Professor of Immunology and Immunotherapy
VP of Innovation and Strategy
Sander van Deventer
Founder and Chief Technology Officer
DIRECTOR PROTEIN THERAPEUTICS
John de Kruif
EVP & CTO at Merus NV
CSO at Denali Therapeutics
Associate Vice President, Biotherapeutics
FOUNDER & CEO OF BIOLOJICDESIGN
CSO at Alchemab Therapeutics
Senior Principal Research Scientist
Prof. Paul W.H.I. Parren
Executive Vice President and Head of R&D
Head of Protein Engineering
Professor in the Departments of Engineering
Head Oncology Discovery
at Roche Innovation Center Zurich
THE ANTIBODY SERIES 2022 Presentations
Presentations on 7th & 8th:
7th Sept 09:00 - 09:30 Joe Lewcock Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle 09:30 - 10:00 Sander van Deventer Next generation vectorized antibody therapies for neurodegenerative diseases 10:00 - 10:15 Panel discussion 10:15 - 11:00 Coffee Break 11:00 - 11:30 Paul Parren Avidity engineering of antibodies 11:30 - 12:00 Peter Tessier Drug-like antibodies by design and directed evolution 12:00 - 12:15 Panel Discussion 12:15 - 13:15 Lunch 13:15 - 14:15 Rene Hoet - New Technology Developments for Future (Multispecific) Antibody Discovery and Optimization 14:15 - 14:45 Yanay Ofran Reimaging therapeutics antibodies using artificial intelligence 14:45 - 15:15 Aridaman Pandit Transforming immunology and target discovery using machine learning 15:15 - 15:30 Panel discussion 15:30 - 16:00 Coffee break 16:00 - 16:30 Jane Osbourn Mining the immune system for protective antibodies 16:30 - 17:00 Marta Amaral Trispecific antibodies as the next generation of T cell immunotherapy 17:00 - 17:30 Daniel Bedinger High resolution epitope binning informs antibody drug discovery and enhances next generation antibody workflows 17:30 - 17:45 Panel discussion 8th Sept 09:00 - 09:30 Pablo Umaña Enhancing endogenous and synthetic immunity with engineered antibody-fusion proteins for cancer immunotherapy 09:30 - 10:00 John de Kruif Discovery of a trispecific T cell engager for solid tumors 10:00 - 10:15 Panel discussion 10:15 - 11:15 Coffee Break 11:15 - 11:45 Nathan Robertson The Two Sides of Targeting Checkpoint Receptors 11:45 - 12:15 Fernando Garces NextGen Biologics Engineering 12:15 - 12:30 Panel Discussion 12:30 - 13:30 Lunch 13:30 - 14:30 Teresa Barata & António Barroso - Flow Eighteen38 Presentation 14:30 - 15:00 Stephen Beers Macrophages and the tumor micro environment 15:00 - 15:30 Horacio Nastri Inhibiting the Adenosine pathway for cancer therapeutics 15:30 - 15:45 Panel discussion 15:45 - 16:15 Coffee break 16:15 - 16:45 Jonathan Davis Using the B-Body Bispecific Platform to Specifically Target and Eliminate Tumor-resident Tregs
Full agenda timings will be available to download in June
Highlights from 2021
Last year's ANTIBODY SERIES was the inaugural event that saw top Industry and Academia minds come together in the spirit of knowledge transfer and sharing of innovative ideas. Speakers included Sir Gregory Winter, Hans Clevers, Ton Logtenberg and many others.